[go: up one dir, main page]

MX2016004961A - Procedimientos y composiciones para el tratamiento de infecciones por s. equi. - Google Patents

Procedimientos y composiciones para el tratamiento de infecciones por s. equi.

Info

Publication number
MX2016004961A
MX2016004961A MX2016004961A MX2016004961A MX2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A
Authority
MX
Mexico
Prior art keywords
methods
treatment
compositions
equi infection
equi
Prior art date
Application number
MX2016004961A
Other languages
English (en)
Inventor
Ellen Ons
Rudiger Raue
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2016004961A publication Critical patent/MX2016004961A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención proporciona procedimientos para el tratamiento o la prevención de S. equi y/o EHV en caballos, comprendiendo los procedimientos administrar a los caballos que lo necesitan una composición que comprende parapoxvirus ovis.
MX2016004961A 2013-10-17 2014-10-15 Procedimientos y composiciones para el tratamiento de infecciones por s. equi. MX2016004961A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361892080P 2013-10-17 2013-10-17
PCT/US2014/060597 WO2015057777A1 (en) 2013-10-17 2014-10-15 Methods and compositions for treatment of s. equi infection

Publications (1)

Publication Number Publication Date
MX2016004961A true MX2016004961A (es) 2016-06-28

Family

ID=51894206

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004961A MX2016004961A (es) 2013-10-17 2014-10-15 Procedimientos y composiciones para el tratamiento de infecciones por s. equi.

Country Status (7)

Country Link
US (1) US20160256540A1 (es)
EP (1) EP3057613A1 (es)
AU (1) AU2014337452A1 (es)
CA (1) CA2927224A1 (es)
MX (1) MX2016004961A (es)
RU (1) RU2016114713A (es)
WO (1) WO2015057777A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105899199A (zh) * 2013-11-26 2016-08-24 硕腾服务有限责任公司 诱导免疫应答的组合物
EP4265266A1 (de) * 2023-03-16 2023-10-25 Patentpool Target GmbH Kit of parts zur therapie von medulloblastomen und diffusen astrozytomen mittels alkoholischer und/oder w ssriger extrakte verschiedener cuscuta spp

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
ZA97452B (en) 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US6649170B1 (en) 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
RU2347586C2 (ru) 2004-04-05 2009-02-27 Пфайзер Продактс Инк. Микрофлюидизированные эмульсии типа "масло в воде" и вакцинные композиции
CA2723786C (en) 2008-06-27 2020-04-28 Pfizer Inc. Novel saponin-containing adjuvants
TW201010719A (en) 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
HRP20181039T1 (hr) 2010-05-28 2018-08-24 Zoetis Belgium S.A. Cjepiva koja sadrže kolesterol i cpg kao jedine molekule koje nose adjuvans

Also Published As

Publication number Publication date
EP3057613A1 (en) 2016-08-24
US20160256540A1 (en) 2016-09-08
WO2015057777A1 (en) 2015-04-23
RU2016114713A (ru) 2017-11-20
CA2927224A1 (en) 2015-04-23
AU2014337452A1 (en) 2016-04-21

Similar Documents

Publication Publication Date Title
IN2015DN01156A (es)
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
MY187540A (en) Compounds active towards bromodomains
PH12015502087B1 (en) Newcastle disease viruses and uses thereof
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PL3656384T3 (pl) Kombinacje zawierające pochodne 5-fenoksy-3h-pirymidyn-4-onu i ich zastosowanie do profilaktyki lub leczenia infekcji hiv
MX2016008448A (es) Conjugados de var2csa-farmaco.
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
MX2016002544A (es) Compuestos utiles como inmunomoduladores.
PH12017500207A1 (en) Indoles for use in influenza virus infection
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
EP2978449A4 (en) Compositions and methods for the treatment or prevention of human immunodeficiency virus infection
IN2013MU03216A (es)
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
MX360885B (es) Nuevas composiciones antifungicas.
PH12015502304A1 (en) Use of pidotimod to treat irritable bowel syndrome
UA92840U (uk) Дегідратаційно-дегреасингаційний розчин для пластинації анатомічних препаратів
UA91618U (uk) Антимікробний засіб паммосепт плюс